ERBA Diagnostics (ERB) Tops Q2 EPS by 1c

ERBA Diagnostics (NYSE: ERB) reported Q2 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $5.16 million.

For earnings history and earnings-related data on ERBA Diagnostics (ERB) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c